Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 4 Next >
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Tags Abbvie Inc LILLY DRN AstraZeneca PLC
From CNBC.com News
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
Tags Breaking News: Business Biotechnology Earnings
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Coca/Cola Co Technology Business
From CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Tags Biotech and Pharmaceuticals LILLY DRN Science
From CNBC.com News
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
Tags Biotech and Pharmaceuticals Breaking news Breaking News: Business
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags KB Home LILLY DRN Abbvie Inc
From CNBC.com News
5 things to know before the stock market opens Monday
Tags CrowdStrike Holdings Inc Markets 5 Things to Know
From CNBC.com News
Thursday's big stock stories: What's likely to move the market in the next trading session
Tags Pentair PLC Trane Technologies PLC Live Nation Entertainment Inc
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Tesla Inc General Motors Co Politics
From CNBC.com News
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
Tags Alzheimer's disease Business News Breaking News: Business
From CNBC.com News
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
Tags Breaking News: Earnings US: News Biogen Inc
From CNBC.com News
Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
Tags Health & Science Companies Eisai Co Ltd
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags Breaking News: Business Science Novo Nordisk A/S
From CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
Tags Health care industry Health & Science Companies
From CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
Tags Markets Investing stocks
From CNBC.com News
Cramer's Lightning Round: Bank of America is a buy
Tags Bank of America Corp S&P 500 Kratos Defense and Security Solutions Inc
From CNBC.com News
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
Tags US: News Pharmaceuticals Biogen Inc
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Investment strategy Enphase Energy Inc Markets
From CNBC.com News
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
Tags Biotech and Pharmaceuticals Biotechnology Business
From CNBC.com News
Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
Tags Healthy Returns Biotech and Pharmaceuticals Science
From CNBC.com News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
Tags Breaking news Biotech and Pharmaceuticals Business News
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Economy Verizon Communications Inc Microsoft Corp
From CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
Tags Business News Biotechnology Business
From CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
Tags Eli Lilly and Co Biogen Inc US: News
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Lucid Group Inc Lyft Inc Under Armour Inc
From CNBC.com News
More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
Tags Breaking news Biotech and Pharmaceuticals Business News
From CNBC.com News
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
Tags Breaking news Biotech and Pharmaceuticals Business News
From CNBC.com News
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
Tags stocks Intel Corp Markets
From CNBC.com News
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
Tags Raytheon Technologies Corp F5 Inc General Motors Co
From CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
Tags Business News Biotechnology Business
From CNBC.com News
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.